![Galya Blachman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Galya Blachman
Consigliere Generale presso
501 ACQU
Profilo
Galya D.
Blachman is currently Chief Legal Officer & Head-Business Development at Enliven Therapeutics, Inc. since 2023.
Legal Advisor at 5AM Venture Management LLC since 2022.
Secretary & General Counsel at 5:01 Acquisition Corp.
since 2020.
General Counsel at Biotech Connection-Bay Area, Inc. since 2018.
Formerly Legal Director at Stemcentrx, Inc. from 2012 to 2017.
Also worked as Head-Legal, Research & Development at AbbVie Stemcentrx LLC.
Education includes a doctorate from the University of Cambridge in 2004, a graduate degree from the University of Oxford in 2009, graduate and undergraduate degrees from the University of Cape Town in 2001 and 2000 respectively, and a graduate degree from BPP Law School in 2006.
Posizioni attive di Galya Blachman
| Società | Posizione | Inizio |
|---|---|---|
| 501 ACQU | Consigliere Generale | 01/09/2020 |
| ENLIVEN THERAPEUTICS, INC. | Consigliere Generale | 01/07/2023 |
Biotech Connection-Bay Area, Inc.
 Biotech Connection-Bay Area, Inc. Biotech Connection-Bay Area, Inc. is a non-profit organization that connects academic science trainees with the biotech industry. The private company is based in California. The organization provides hands-on consulting and due diligence projects to clients in the life sciences sector, focusing on market research, pipeline prioritization, competitive landscaping, business development, and new product strategy. Its projects span areas such as cancer screening, genomic medicine, neurodegenerative diseases, and drug discovery platforms. Biotech Connection-Bay Area also offers experiential learning opportunities to help trainees build business and consulting skills for non-academic careers in life sciences, publishes articles and market reports on biotech topics, promotes diversity, equity, and inclusion initiatives, and engages the community through events and communications. | Consigliere Generale | 01/06/2018 |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Consigliere Generale | 01/09/2018 |
Precedenti posizioni note di Galya Blachman
| Società | Posizione | Fine |
|---|---|---|
Stemcentrx, Inc.
 Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | Consigliere Generale | 01/01/2017 |
AbbVie Stemcentrx LLC | Corporate Officer/Principal | - |
Formazione di Galya Blachman
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
89
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cape Town
 University of Cape Town Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Finance |
BPP Law School
 BPP Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AbbVie Stemcentrx LLC | |
5:01 Acquisition Corp.
 5:01 Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Biotech Connection-Bay Area, Inc.
Biotech Connection-Bay Area, Inc. Biotech Connection-Bay Area, Inc. is a non-profit organization that connects academic science trainees with the biotech industry. The private company is based in California. The organization provides hands-on consulting and due diligence projects to clients in the life sciences sector, focusing on market research, pipeline prioritization, competitive landscaping, business development, and new product strategy. Its projects span areas such as cancer screening, genomic medicine, neurodegenerative diseases, and drug discovery platforms. Biotech Connection-Bay Area also offers experiential learning opportunities to help trainees build business and consulting skills for non-academic careers in life sciences, publishes articles and market reports on biotech topics, promotes diversity, equity, and inclusion initiatives, and engages the community through events and communications. | |
Enliven Therapeutics, Inc.
 Enliven Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage precision oncology company that develops molecule therapies | Health Technology |
